Skip to content

KARIPHARMA

Active
Private limited companyfounded 2003active for 23 yearsKerkstraat 14, 1742 Ternat, BelgiumKBO/BCE: BE 0479.817.428
Summary

KARIPHARMA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €632,727 and a net result of €108,353. Equity is growing by about 4.4% per year across the filed financial years. Its solvency ranks better than 79% of 2,795 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

On 21 March 2003, KARIPHARMA was incorporated.1 Total assets went from €787,614 in 2018 to €827,778 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
17-06
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Back to profitnet €108,353
Net result €108,353 after one loss-making year.
23-06
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Weakest financial yearnet -€35,216
Net result drops to -€35,216, the lowest in the series; recovery starts the following year.
24-06
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
01-03
Gazette deed Appointment: PHARMADA (director)
Permanent representative: BROECHOVEN Kristel · Legal-form conversion · Purpose change11 facts ▸
  • General meeting, “buitengewone algemene vergadering” (deed in Dutch)
  • Legal-form conversion, “besloten vennootschap(BV)” (deed in Dutch)
  • Other provision, “verslag bestuursorgaan over voorwerpwijziging, dossier van de notaris” (deed in Dutch)
  • Purpose change
  • Capital conversion, “artikel 39,§2,tweede lid wet van 2019-03-23, niet-opgevraagde inbrengen” (deed in Dutch)
  • Other provision, “opheffing statutair onbeschikbare eigen vermogensrekening, middelen beschikbaar voor uitkering” (deed in Dutch)
  • Other provision, “bij uittreksel, voormelde beslissingen” (deed in Dutch)
  • Director appointment, PHARMADA (director (not named in the articles))
  • Permanent representative, BROECHOVEN Kristel
  • Registered office clause, “1742 Ternat,Kerkstraat 14” (deed in Dutch)
  • Power of attorney
2023
29-06
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
2022
16-06
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
17-06
NBB filing Annual accounts filed
financial year 2020 · abbreviated format
2020
31-07
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
2019
31-12
Financial Equity above €500,000equity €513,493 ▲13.2%
A profit in every financial year since 2018 builds equity to €513,493.
19-07
NBB filing Annual accounts filed
financial year 2018 · abbreviated format
2018
25-06
NBB filing Annual accounts filed
financial year 2017 · abbreviated format
2017
26-06
NBB filing Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 22 annual accounts filed, the latest 10 are here; all 22 are under Financials.
1 of 3 deeds read
About the unread acts

Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.